Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Waxonova
- Development stage
- Unknown
- Lead developer
- Circius Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Waxonova is an over-the-counter (OTC) ear care product line developed and marketed by Circius Pharma, a Swedish pharmaceutical and MedTech company. The range consists of ear sprays designed to manage earwax and maintain ear canal health. Specifically, the formulations are used to dissolve earwax plugs, facilitate the removal of excess cerumen, and cleanse the ear canal. Additionally, certain products within the line, such as Waxonova Dry Ear, are intended to relieve irritation and itching associated with dry ear canals. Marketed as a natural and simple solution for ear hygiene, Waxonova is primarily available in Scandinavian markets, including Sweden, Norway, and Denmark.
- Brand names
- Waxonova
Beyond the preview
Go deeper on Waxonova.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Waxonova.